Eyenovia to present at upcoming btig ophthalmology day

New york, nov. 23, 2022 (globe newswire) -- eyenovia, inc. (nasdaq: eyen), a pre-commercial ophthalmic technology company developing the optejet® delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will present at the btig ophthalmology day taking place virtually on november 29, 2022. presentation details are below:
EYEN Ratings Summary
EYEN Quant Ranking